Crystal Structure of the Fab Fragment of an Anti-CTLA-4 Antibody, Ipilimumab, Used for Cancer Immunotherapy
Lee, J.Y., Lee, H.T., Lee, S.H., Lim, H., Heo, Y.S.(2019) Bull Korean Chem Soc 40: 582-585
Experimental Data Snapshot
wwPDB Validation 3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
ipilimumab fab heavy chain | A [auth H] | 230 | Homo sapiens | Mutation(s): 0 | ![]() |
Entity Groups | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
ipilimumab fab light chain | B [auth L] | 215 | Homo sapiens | Mutation(s): 0 | ![]() |
Entity Groups | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
SO4 Query on SO4 | C [auth H], D [auth H], E [auth H], F [auth L] | SULFATE ION O4 S QAOWNCQODCNURD-UHFFFAOYSA-L |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 119.614 | α = 90 |
b = 119.614 | β = 90 |
c = 82.597 | γ = 90 |
Software Name | Purpose |
---|---|
HKL-2000 | data reduction |
HKL-2000 | data scaling |
PHASER | phasing |
PHENIX | refinement |
PDB_EXTRACT | data extraction |